Close

More on HSKA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-100.0% Growth)
- Ratings (6.2 Score)
- Holders
- Dividends (0.3% Yield)

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/7/23 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

HSKA Income Statement

Click line-items for a historical chart and %
Revenue, net:
Core companion animal health 26.39M
Other vaccines, pharmaceuticals and products 7.04M
Total revenue, net 33.43M
Cost of revenue 19.71M
Gross profit 13.72M
Operating expenses:
Selling and marketing 5.49M
Research and development 507K
General and administrative 3.23M
Total operating expenses 9.23M
Operating income (loss) 4.49M
Interest and other expense, net
Income (loss) before income taxes 4.48M
Current tax expense 123K
Deferred tax expense (benefit) 1.01M
Total income tax expense (benefit) 1.14M
Net income (loss) 3.35M
Basic net income (loss) per share 0.49
Diluted net income (loss) per share 0.45
Weighted average outstanding shares used to compute basic net income (loss) per share
Weighted average outstanding shares used to compute diluted net income (loss) per share 7.45M

Entities mentioned with HSKA

View All Entities